Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
732,338
-
Share change
-
+57,200
-
Total reported value
-
$110,460,525
-
Put/Call ratio
-
0%
-
Price per share
-
$150.79
-
Number of holders
-
83
-
Value change
-
+$8,530,469
-
Number of buys
-
23
-
Number of sells
-
51
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2019
As of 30 Jun 2019,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
732,338 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BROWN ADVISORY INC, JANE STREET GROUP, LLC, ROYAL BANK OF CANADA, BIEGEL & WALLER LLC, MURPHY CAPITAL MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.